UB-621, a New Type of Anti-herpes Simplex Virus (HSV) Monoclonal Antibody for the Use in the Treatment of Adult Recurrent HSV-2 Infections of the Genitals

Condition:   Recurrent Genital Herpes Intervention:   Biological: UB-621 Sponsor:   UBP Greater China (Shanghai) Co., Ltd Not yet recruiting

Source: ClinicalTrials.gov - January 19, 2021 Category: Research Source Type: clinical trials